As the pharmaceutical industry shifts towards advanced therapeutic solutions utilizing monoclonal antibodies and cell and gene therapies, there is a growing shift towards personalized, smaller batch sizes in contrast to larger batch sizes associated with traditional medicinal products.
As the pharmaceutical industry shifts towards advanced therapeutic solutions utilizing monoclonal antibodies and cell and gene therapies, there is a growing shift towards personalized, smaller batch sizes in contrast to larger batch sizes associated with traditional medicinal products.